DK286990D0 - Indanderivater - Google Patents
IndanderivaterInfo
- Publication number
- DK286990D0 DK286990D0 DK286990A DK286990A DK286990D0 DK 286990 D0 DK286990 D0 DK 286990D0 DK 286990 A DK286990 A DK 286990A DK 286990 A DK286990 A DK 286990A DK 286990 D0 DK286990 D0 DK 286990D0
- Authority
- DK
- Denmark
- Prior art keywords
- optionally substituted
- alkyl
- hydroxy
- hydrogen
- cycloalkyl
- Prior art date
Links
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical class C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000002030 1,2-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([*:2])C([H])=C1[H] 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 239000003215 serotonin 5-HT2 receptor antagonist Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (20)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK286990A DK286990D0 (da) | 1990-12-04 | 1990-12-04 | Indanderivater |
| IE407691A IE914076A1 (en) | 1990-12-04 | 1991-11-22 | Indan derivatives |
| NZ240734A NZ240734A (en) | 1990-12-04 | 1991-11-26 | 5-substituted-trans-1-piperazinoindan derivatives; their preparation and |
| IL10016491A IL100164A (en) | 1990-12-04 | 1991-11-27 | 5-substituted-1-piperazinoindan derivatives method for their preparation and pharmaceutical preparations and medicaments containing them |
| AU89599/91A AU653375B2 (en) | 1990-12-04 | 1991-11-28 | Indan derivatives |
| PCT/DK1991/000358 WO1992010192A1 (en) | 1990-12-04 | 1991-11-28 | Indan derivatives |
| JP50028192A JP3245418B2 (ja) | 1990-12-04 | 1991-11-28 | インダン誘導体 |
| AT92900941T ATE121294T1 (de) | 1990-12-04 | 1991-11-28 | Indanderivate. |
| DE69109132T DE69109132T2 (de) | 1990-12-04 | 1991-11-28 | Indanderivate. |
| KR1019930701680A KR930702980A (ko) | 1990-12-04 | 1991-11-28 | 인단 유도체 |
| EP92900941A EP0560868B1 (en) | 1990-12-04 | 1991-11-28 | Indan derivatives |
| ES92900941T ES2071479T3 (es) | 1990-12-04 | 1991-11-28 | Derivados de indano. |
| CA002097715A CA2097715C (en) | 1990-12-04 | 1991-11-28 | Indan derivatives |
| DK92900941.3T DK0560868T3 (da) | 1990-12-04 | 1991-11-28 | Indan derivater |
| PT99673A PT99673B (pt) | 1990-12-04 | 1991-12-03 | Processo para a preparacao de derivados de 1-piperazino-indano e de composicoes farmaceuticas que os contem |
| ZA919563A ZA919563B (en) | 1990-12-04 | 1991-12-04 | Indan derivatives |
| NO932024A NO179947C (no) | 1990-12-04 | 1993-06-03 | Indanderivater |
| FI932541A FI105685B (fi) | 1990-12-04 | 1993-06-03 | Menetelmä uusien terapeuttisesti käyttökelpoisten 5-substituoitujen trans-1-piperatsinoindaanijohdannaisten ja niiden farmaseuttisesti hyväksyttävien happoadditiosuolojen valmistamiseksi |
| US08/383,708 US5643784A (en) | 1990-12-04 | 1995-02-01 | Indan derivatives |
| HK122995A HK122995A (en) | 1990-12-04 | 1995-07-27 | Indan derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK286990A DK286990D0 (da) | 1990-12-04 | 1990-12-04 | Indanderivater |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK286990D0 true DK286990D0 (da) | 1990-12-04 |
Family
ID=8116621
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK286990A DK286990D0 (da) | 1990-12-04 | 1990-12-04 | Indanderivater |
| DK92900941.3T DK0560868T3 (da) | 1990-12-04 | 1991-11-28 | Indan derivater |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92900941.3T DK0560868T3 (da) | 1990-12-04 | 1991-11-28 | Indan derivater |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0560868B1 (no) |
| JP (1) | JP3245418B2 (no) |
| KR (1) | KR930702980A (no) |
| AT (1) | ATE121294T1 (no) |
| AU (1) | AU653375B2 (no) |
| CA (1) | CA2097715C (no) |
| DE (1) | DE69109132T2 (no) |
| DK (2) | DK286990D0 (no) |
| ES (1) | ES2071479T3 (no) |
| FI (1) | FI105685B (no) |
| HK (1) | HK122995A (no) |
| IE (1) | IE914076A1 (no) |
| IL (1) | IL100164A (no) |
| NO (1) | NO179947C (no) |
| NZ (1) | NZ240734A (no) |
| PT (1) | PT99673B (no) |
| WO (1) | WO1992010192A1 (no) |
| ZA (1) | ZA919563B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| DK55192D0 (da) * | 1992-04-28 | 1992-04-28 | Lundbeck & Co As H | 1-piperazino-1,2-dihydroindenderivater |
| DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| SK94393A3 (en) * | 1992-09-11 | 1994-08-10 | Thomae Gmbh Dr K | Cyclic derivatives of urea, process for their production and their pharmaceutical agents with the content of those |
| JP2000514060A (ja) * | 1996-07-01 | 2000-10-24 | シェーリング コーポレイション | ムスカリン様アンタゴニスト |
| US5935958A (en) * | 1996-07-01 | 1999-08-10 | Schering Corporation | Muscarinic antagonists |
| TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
| IS7282A (is) * | 2001-12-21 | 2004-05-21 | H. Lundbeck A/S | Amínóindan afleiður sem serótónín og noradrenalínupptökuhindrar |
| MXPA04006119A (es) * | 2001-12-21 | 2004-11-01 | Lundbeck & Co As H | Derivados aminoindano como inhibidores de la absorcion de la serotonina y de la norepinefrina. |
| FR2883876B1 (fr) * | 2005-03-30 | 2007-05-04 | Servier Lab | Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TW200819426A (en) | 2006-08-31 | 2008-05-01 | Lundbeck & Co As H | Novel indane compounds |
| KR101939546B1 (ko) | 2011-06-20 | 2019-01-16 | 하. 룬드벡 아크티에셀스카브 | 정신 분열증의 치료를 위한 중수소화 1-피페라지노-3-페닐 인단 |
| CN113056457B (zh) * | 2018-12-03 | 2025-06-20 | H.隆德贝克有限公司 | 用于治疗cns疾病的前药 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE50867B1 (en) * | 1980-02-29 | 1986-08-06 | Kefalas As | Indane derivatives |
| GB8427125D0 (en) * | 1984-10-26 | 1984-12-05 | Lundbeck & Co As H | Organic compounds |
-
1990
- 1990-12-04 DK DK286990A patent/DK286990D0/da not_active Application Discontinuation
-
1991
- 1991-11-22 IE IE407691A patent/IE914076A1/en not_active IP Right Cessation
- 1991-11-26 NZ NZ240734A patent/NZ240734A/en not_active IP Right Cessation
- 1991-11-27 IL IL10016491A patent/IL100164A/en not_active IP Right Cessation
- 1991-11-28 EP EP92900941A patent/EP0560868B1/en not_active Expired - Lifetime
- 1991-11-28 KR KR1019930701680A patent/KR930702980A/ko not_active Ceased
- 1991-11-28 CA CA002097715A patent/CA2097715C/en not_active Expired - Fee Related
- 1991-11-28 JP JP50028192A patent/JP3245418B2/ja not_active Expired - Fee Related
- 1991-11-28 AU AU89599/91A patent/AU653375B2/en not_active Ceased
- 1991-11-28 ES ES92900941T patent/ES2071479T3/es not_active Expired - Lifetime
- 1991-11-28 AT AT92900941T patent/ATE121294T1/de not_active IP Right Cessation
- 1991-11-28 DE DE69109132T patent/DE69109132T2/de not_active Expired - Fee Related
- 1991-11-28 WO PCT/DK1991/000358 patent/WO1992010192A1/en not_active Ceased
- 1991-11-28 DK DK92900941.3T patent/DK0560868T3/da active
- 1991-12-03 PT PT99673A patent/PT99673B/pt not_active IP Right Cessation
- 1991-12-04 ZA ZA919563A patent/ZA919563B/xx unknown
-
1993
- 1993-06-03 FI FI932541A patent/FI105685B/fi active
- 1993-06-03 NO NO932024A patent/NO179947C/no not_active IP Right Cessation
-
1995
- 1995-07-27 HK HK122995A patent/HK122995A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2097715C (en) | 2003-04-15 |
| DE69109132T2 (de) | 1995-08-31 |
| NO179947C (no) | 1997-01-15 |
| NO179947B (no) | 1996-10-07 |
| DK0560868T3 (da) | 1995-10-02 |
| ZA919563B (en) | 1992-08-26 |
| WO1992010192A1 (en) | 1992-06-25 |
| AU8959991A (en) | 1992-07-08 |
| NZ240734A (en) | 1994-02-25 |
| CA2097715A1 (en) | 1992-06-05 |
| KR930702980A (ko) | 1993-11-29 |
| IL100164A0 (en) | 1992-08-18 |
| JPH06503073A (ja) | 1994-04-07 |
| IL100164A (en) | 1996-06-18 |
| PT99673B (pt) | 1999-05-31 |
| NO932024L (no) | 1993-07-30 |
| IE914076A1 (en) | 1992-06-17 |
| FI105685B (fi) | 2000-09-29 |
| PT99673A (pt) | 1992-10-30 |
| EP0560868B1 (en) | 1995-04-19 |
| DE69109132D1 (de) | 1995-05-24 |
| AU653375B2 (en) | 1994-09-29 |
| EP0560868A1 (en) | 1993-09-22 |
| HK122995A (en) | 1995-08-04 |
| ES2071479T3 (es) | 1995-06-16 |
| NO932024D0 (no) | 1993-06-03 |
| ATE121294T1 (de) | 1995-05-15 |
| FI932541A7 (fi) | 1993-07-23 |
| JP3245418B2 (ja) | 2002-01-15 |
| FI932541A0 (fi) | 1993-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE115576T1 (de) | Neue indolderivate. | |
| DK0560868T3 (da) | Indan derivater | |
| DE69105659D1 (de) | 3-Arylindol- und 3-Arylindazolderivate. | |
| NO942686L (no) | Anvendelse av 3-arylindol- og 3-arylindazolderivater ved behandling av psykoser | |
| PT1068199E (pt) | N-ariloxietil-indoli-alquilaminas para o tratamento da depressao |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |